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ESSENTIAL DRUGS AND THEIR R O L E IN T H E 
HOSPITAL DRUG CONSUMPTION IN T H E UNITED 
REGIONAL CLINICAL HOSPITAL-VARNA IN 1997 
V. Eliseev, E . Milev*, A. Belcheva* 
United Regional Clinical Hospital of Varna and ^Department of Pharmacology, 
Medical University of Varna, Varna 
The consumption of the drugs included in the Model List of Essential Drugs 
(ED) of WHO was studied in the United Regional Clinical Hospital of Varna for the 
first time. The purpose of the study was to estimate the consumption of these drugs in 
the hospital as a whole as well as in every hospital division. The monthly variations of 
the consumption were analyzed according to the specific activity of these divisions. 
The mean ED consumption by the patients in all the divisions was calculated. Those of 
them with the highest frequency of ED usage recommended in the Model List were 
presented. Certain conclusions about the benefit of the introduction of this Model List 
of ED and its importance for some hospital pharmaco-economic factors were drawn. 
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New developments in social life 
and related changes in the business envi-
ronment lead to restructuring the drug 
market and rationaling the roles of com-
panies and consumers. These changes put 
new requirements to the governmental 
hospitals' behaviour. The elaboration of a 
drug policy taking into account the speci-
ficity of each hospital becomes a major 
riority. A substantial element of the hos-
pital drug policy is the elaboration and 
approval of a list of used drugs. It is based 
international and local standards exist-
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ing in this field and on the particular needs 
of every clinic or hospital. Regardless of 
the limitation of physicians' access to drugs 
and the resulting decreased freedom in 
their clinical practice it is extremely impor-
tant to the rationalization of the drug con-
sumption. 
Since 1977, the World Health Or-
ganization (WHO) regularly assesses the 
consumption of drugs and recommends to 
medical community these of them that, 
because of their effectiveness, safety, in-
contestable therapeutic qualities and good 
pharmacoeconomical profile, have be-
come a reliable treatment standard. They 
are included in the Model List of W H O 
and are known as Essential Drugs ( E D ) . 
They meet the needs of the majority of the 
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population and are available at every mo­
ment and level in the health care system. 
The Bulgarian Model List for hospital drug 
use is based on them, too. A widely known 
weakness of the hospitals in Bulgaria is the 
use of too many drugs per patient 
(polypragmasia) which can be classified 
as irrational and "infatuation in fashion". 
At the same time, W H O has long ago 
proved that the necessary hospital medi­
cations are between 100 and 200, de­
pending on the place of the hospital in the 
national health care system. That is why 
the hospital lists can become a major and 
rational regulator of the drug therapy, par­
ticularly until the approval of criteria of 
Good Clinical Practice (GCP) . 
The aim of this study is to assess 
the extent to which the use of drugs in the 
United Regional Clinical Hospital of Varna 
(URCH-Varna) conforms to the Model 
List of E D of W H O , Revision of Decem­
ber, 1995 (3), and whether the prescrip­
tion of the E D has a priority over that of 
the others. 
MATERIAL AND METHODS 
The subject of this trial is the drug 
use of all medications prescribed in the 
URCH-Varna during the period from Janu­
ary 1,1 997 till December 31,1997 with 
exception of those either used for less than 
9 months, or provided as humanitarian aid. 
A total of 510 drugs from all pharmaco­
logical groups according to the Hospital 
drug list are included. The medications are 
divided into three groups taking into ac­
count their conformity to the Model List 
of E D of W H O . 
Statistical methods (variation 
analysis, Student's f-criterion) are used to 
compare the groups (2). 
RESULTS AND DISCUSSION 
The monthly consumption of 510 
medications in U R C H - Vama in 1997 was 
established and compared to the Model 
List of E D of WHO. A total of 265 medi­
cations of 172 drug substances were E D , 
which represented only 52 % of the cases. 
The variation in the monthly consumption 
of the drugs in the three studied groups 
was statistically insignificant. The ratio be­
tween the variation in the monthly con­
sumption of drugs and the average one 
could serve as a criterion for the assess­
ment of the stability of preservers' pref­
erence to a particular medication (or medi­
cations). 
This statement was based on the 
argument that the more frequent and regu­
lar the preference of a large group of pre­
scribes to a given drug, the less the varia­
tion in the monthly consumption (Table 1). 
The established average variation 
in the monthly drug consumption in 
URCH-Varna during 1997 was of 78,96 
% 34,36 and indicated the absence of 
stable preferences to particular drugs. The 
value for 1995 was of 72,78 34,37. Con­
sequently, there were no quantitative 
changes in the pathology that could seri­
ously influence on the regularity in the use 
of the drugs, respectively on its average 
variation. The established value of monthly 
variation could hardly be considered as 
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able 1 
Consumption of drugs in URCH-Varna in 1997 
Drugs used in U R C H Group one 





n 510 265 245 
Mean variation 78,96 % 79,78 % 78,08 % 
Standard deviation 34,36 % 37,97 % 30,03 % 
Statistical significance p>0,10 p>0,10 
significant because the role of financial and 
commercial factors could not be ignored. 
The variation in the consumption of non-
essential drugs was less than that of E D 
and that of all the drugs, regardless the fact 
that their number is less. The difference 
was statistically insignificant. 
The study could not establish any 
substantial difference in the preferences of 
the physicians to E D or non-ED. This is a 
disappointing statement as it stresses the 
disparity in the criteria of drug quality and 
effectiveness between Bulgarian medical 
community and the W H O experts. Since 
its creation twenty years ago, the Model 
List of W H O has been modified six times. 
The total number of the active substances 
included has, however, never exceeded 
220. 
The Bulgarian specialists still can 
not make their choice of really useful and 
relatively safe medications among the large 
number of drugs available on the market. 
This explains the polypragmasia and irra-
tional drug use in URCH-Varna already 
detected in our previous studies (1). 
CONCLUSIONS 
1. The drug use in URCH-Varna 
proves to be irrational, not only from the 
quantitative but also from the qualitative 
point of view, because only about 50 % 
of the drugs are essential. 
2. The established disparities are 
most probably due to the lack of adequate 
appraisal of the long-term effectiveness, 
safety and reliable therapeutic qualities df 
drugs on the part of the physicians. 
3. The absence of nationally ac-
cepted criteria for G C P imposes the ap-
plication of the Bulgarian Model list of the 
hospital drug use as a harder, including 
administrative, criterion for rational thera-
peutic policy. 
4. The limitation of the drugs avail-
able in the hospital pharmacy remains the 
most important means for overcoming the 
irrationality in the choice of drug therapy 
and, as the world experience indicates, 
represents a totally pertinent and legally 
approved component of the hospital man-
agement. 
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Роля на основните лекарствени средства ("Essential drugs") в 
болничното лекарствено потребление на ОРКБ-Варна през 1997 г. 
В. Елисеев, Е. Милев*, А. Белчева* 
ОРКБ-Варна и *Катедра по фармакология, Медицински университет-Варна 
Резюме: За пръв път в ОРКБ-Варна бе проучена консумацията на лекарствените 
средства, включени в моделната листа на СЗО за "Essential drugs" (ED). Целта на 
проучването бе да се определи консумацията на тези лекарствени средства в 
болницата като цяло и за всяко болнично отделение. Анализирани бяха месечните 
вариации в потреблението в зависимост от специфичната дейност на тези отделения. 
Изчислена бе средната консумация на E D от пациентите във всички отделения. 
Представени бяха отделенията с най-висока честота на използване на препоръчаните 
в ED-листата медикаменти. Направени бяха някои изводи за полезността от 
въвеждането на моделната листа за "Essential drugs" и значението й за някои фармако-
икономически фактори на болницата. 
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